Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) General Information
Description
A portfolio of oncology programs. The portfolio consists of a skin-directed HDAC inhibitor and bivalent SMAC mimetic, used in the treatment of cancer.
Contact Information
Corporate Office
- 343 Phoenixville Pike
- Malvern, PA 19355
- United States
Corporate Office
- 343 Phoenixville Pike
- Malvern, PA 19355
- United States
Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) FAQs
-
Where is Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) headquartered?
Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) is headquartered in Malvern, PA.
-
What industry is Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) in?
Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs)’s primary industry is Other Healthcare Technology Systems.
-
Is Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) a private or public company?
Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) is a Private company.
-
What is the current valuation of Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs)?
The current valuation of Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) is .
-
What is Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs)’s current revenue?
The current revenue for Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) is .
-
Who are Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs)’s investors?
TetraLogic Pharmaceuticals has invested in Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs).
-
When was Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) acquired?
Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) was acquired on 29-Dec-2016.
-
Who acquired Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs)?
Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) was acquired by Medivir.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process